About Frontier

Leadership

Executive Team
Board of Directors
Scientific Advisory Board

Executive Team

Monique Bobadilla
Chief People and Culture Officer

View Bio

Mark Dizon, J.D.
General Counsel

View Bio

Daniel Erlanson, Ph.D.
Chief Innovation Officer

View Bio

Victoria "Tori" Fort
Senior Vice President, Strategy and Corporate Affairs

View Bio

Johannes Hermann, Ph.D.
Chief Technology Officer

View Bio

Lata Jayaraman, Ph.D.
Senior Vice President and Head of Oncology and Inflammatory Disease Research

View Bio

Anne Keating, Pharm.D
Senior Vice President, Head of Clinical Development Operations and Program Management

View Bio

Andrew Krivoshik, M.D., Ph.D.
Chief Medical Officer

View Bio

Gerardo Ubaghs
Chief Financial Officer

View Bio

Chris Varma, Ph.D.
Co-founder, Chairman and CEO

View Bio

Kevin Webster, Ph.D.
Chief Scientific Officer

View Bio

Board of Directors

Derek DiRocco, Ph.D.

RA Capital Management

Luke Evnin, Ph.D.

MPM Capital

David M. Goldstein, Ph.D.

Independent Member

Pamela M. Klein, M.D.

Independent Member

Othman Laraki

Independent Member

Janwillem Naesens

DROIA Oncology Ventures

Sisi Pouraghabagher

Independent Member

Chris Varma, Ph.D.

Frontier Medicines

Cameron Wheeler, Ph.D.

Deerfield Management

Scientific Advisory Board

Joan S. Brugge, Ph.D.

Harvard Ludwig Cancer Center

Giulio Draetta, M.D., Ph.D.

The University of Texas
MD Anderson Cancer Center

Steven Gygi, Ph.D.

Harvard Medical School

William C. Hahn, M.D., Ph.D.

Dana-Farber Cancer Institute

Pasi A. Jänne, M.D., Ph.D.

Dana-Farber Cancer Institute

Kevin Koch, Ph.D.

OrbiMed
(Formerly Array BioPharma)

Scott Kopetz, M.D., Ph.D., FACP

The University of Texas
MD Anderson Cancer Center

Piro Lito, M.D., Ph.D.

Memorial Sloan Kettering Cancer Center
(MSK)

Daniel K. Nomura, Ph.D.

Co-founder of Frontier;
U.C. Berkeley

Roberto Zoncu, Ph.D.

Co-founder of Frontier;
U.C. Berkeley